Subjective Responses to Intravenous Nicotine: Greater Sensitivity in Women Than in Men

Experimental and Clinical Psychopharmacology

Volumn 17, Issue 2, 2009, Pages 63-69

  Sofuoglu, Mehmet ^a   Mooney, Marc ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

gender differences; intravenous nicotine; nicotine; sex differences

Indexed keywords

NICOTINE;

ADULT; ARTICLE; BRIEF QUESTIONNAIRE ON SMOKING URGES; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG RESPONSE; DRUG SENSITIVITY; EXPERIENCE; FEMALE; HEART RATE; HUMAN; MALE; QUESTIONNAIRE; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TOBACCO DEPENDENCE;

ADULT; BLOOD PRESSURE; CONTROLLED CLINICAL TRIALS AS TOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; QUESTIONNAIRES; SEX FACTORS; SMOKING; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 65249187720     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0015297     Document Type: Article

References (56)

1. Battig K., Buzzi R., and Nil R. Smoke yield of cigarettes and puffing behavior in men and women. Psychopharmacology 76 (1982) 139-148
2. Bell S.L., Taylor R.C., Singleton E.G., Henningfield J.E., and Heishman S.J. Smoking after nicotine deprivation enhances cognitive performance and decreases tobacco craving in drug abusers. Nicotine & Tobacco Research 1 (1999) 45-52
3. Benowitz N.L., and Hatsukami D.K. Gender differences in the pharmacology of nicotine addiction. Addiction Biology 3 (1998) 383-404
4. Benowitz N.L., Lessov-Schlaggar C.N., Swan G.E., and Jacob III P. Female sex and oral contraceptive use accelerate nicotine metabolism. Clinical Pharmacology and Therapeutics 79 (2006) 480-488
5. Booze R.M., Welch M.A., Wood M.L., Billings K.A., Apple S.R., and Mactutus C.F. Behavioral sensitization following repeated intravenous nicotine administration: Gender differences and gonadal hormones. Pharmacology, Biochemistry and Behavior 64 (1999) 827-839
6. Centers for Disease Control. Annual smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 1997-2001. MMWR 54 (2005) 625-628
7. Cepeda-Benito A., Reynoso J.T., and Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: Differences between men and women. Journal of Consulting and Clinical Psychology 72 (2004) 712-722
8. Chait L.D., Corwin R.L., and Johanson C.E. A cumulative dosing procedure for administering marijuana smoke to humans. Pharmacology, Biochemistry and Behavior 29 (1988) 553-557
9. Chaudhri N., Caggiula A.R., Donny E.C., Booth S., Gharib M.A., Craven L.A., et al. Sex differences in the contribution of nicotine and nonpharmacological stimuli to nicotine self-administration in rats. Psychopharmacology (Berlin) 180 (2005) 258-266
10. Cox L.S., Tiffany S.T., and Christen A.G. Evaluation of the Brief Questionnaire of Smoking Urges (QSU-Brief) in laboratory and clinical settings. Nicotine & Tobacco Research 3 (2001) 7-16
11. Damaj M.I. Influence of gender and sex hormones on nicotine acute pharmacological effects in mice. Journal of Pharmacology and Experimental Therapeutics 296 (2001) 132-140
12. Donny E.C., Caggiula A.R., Rowell P.P., Gharib M.A., Maldovan V., Booth S., et al. Nicotine self-administration in rats: Estrous cycle effects, sex differences and nicotinic receptor binding. Psychopharmacology (Berlin) 151 (2000) 392-405
13. Eissenberg T., Adams C., Riggins III E.C., and Likness M. Smokers' sex and the effects of tobacco cigarettes: Subject-rated and physiological measures. Nicotine & Tobacco Research 1 (1999) 317-324
14. Evans S.E., Blank M., Sams C., Weaver M.F., and Eissenberg T. Transdermal nicotine-induced tobacco abstinence symptom suppression: Nicotine dose and smokers' gender. Experimental and Clinical Psychopharmacology 14 (2006) 121-135
15. Grunberg N.E., Bowen D.J., and Winders S.E. Effects of nicotine on body weight and food consumption in female rats. Psychopharmacology (Berlin) 90 (1986) 101-105
16. Harrod S.B., Mactutus C.F., Bennett K., Hasselrot U., Wu G., Welch M., et al. Sex differences and repeated intravenous nicotine: Behavioral sensitization and dopamine receptors. Pharmacology, Biochemistry and Behavior 78 (2004) 581-592
17. Harvey D.M., Yasar S., Heishman S.J., Panlilio L.V., Henningfield J.E., and Goldberg S.R. Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers. Psychopharmacology (Berlin) 175 (2004) 134-142
18. Hatchell P.C., and Collins A.C. The influence of genotype and sex on behavioral sensitivity to nicotine in mice. Psychopharmacology (Berlin) 71 (1980) 45-49
19. Heatherton T.F., Kozlowski L.T., Frecker R.C., and Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addictions 86 (1991) 1119-1127
20. Henningfield J.E., Miyasato K., and Jasinski D.R. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. Journal of Pharmacology and Experimental Therapeutics 234 (1985) 1-12
21. Hofer I., Nil R., Wyss F., and Battig K. The contributions of cigarette yield, consumption, inhalation and puffing behaviour to the prediction of smoke exposure. Clinical Investigator 70 (1992) 343-351
22. Hoffmann D., and Wynder E.L. Chemical constituents and bioactivity of tobacco smoke. IARC Scientific Publications 1986 (1986) 145-165
23. Houtsmuller E.J., Fant R.V., Eissenberg T.E., Henningfield J.E., and Stitzer M.L. Flavor improvement does not increase abuse liability of nicotine chewing gum. Pharmacology, Biochemistry and Behavior 72 (2002) 559-568
24. Houtsmuller E.J., Henningfield J.E., and Stitzer M.L. Subjective effects of the nicotine lozenge: Assessment of abuse liability. Psychopharmacology (Berlin) 167 (2003) 20-27
25. Jones H.E., Garrett B.E., and Griffiths R.R. Subjective and physiological effects of intravenous nicotine and cocaine in cigarette smoking cocaine abusers. Journal of Pharmacology and Experimental Therapeutics 288 (1999) 188-197
26. Killen J.D., Fortmann S.P., Varady A., and Kraemer H.C. Do men outperform women in smoking cessation trials? Maybe, but not by much. Experimental and Clinical Psychopharmacology 10 (2002) 295-301
27. Marks J.L., Pomerleau C.S., and Pomerleau O.F. Effects of menstrual phase on reactivity to nicotine. Addictive Behavior 24 (1999) 127-134
28. McCance-Katz E.F., Hart C.L., Boyarsky B., Kosten T., and Jatlow P. Gender effects following repeated administration of cocaine and alcohol in humans. Substance Use and Misuse 40 (2005) 511-528
29. McNair D., Lorr M., and Droppleman L. Profile of Mood States: Bipolar form (1988), EdITS, San Diego, CA
30. Morgan M.J., Davies G.M., and Willner P. The Questionnaire of Smoking Urges is sensitive to abstinence and exposure to smoking-related cues. Behavioural Pharmacology 10 (1999) 619-626
31. Myers C.S., Taylor R.C., Moolchan E.T., and Heishman S.J. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray. Neuropsychopharmacology 33 (2008) 588-598
32. Netter P., Muller M.J., Neumann A., and Kamradik B. The influence of nicotine on performance, mood, and physiological parameters as related to smoking habit, gender, and suggestibility. Clinical Investigator 72 (1994) 512-518
33. Perkins K.A. Individual variability in responses to nicotine. Behavior Genetics 25 (1995) 119-132
34. Perkins K.A. Sex differences in nicotine versus non-nicotine reinforcement as determinants of tobacco smoking. Experimental and Clinical Psychopharmacology 4 (1996) 1-12
35. Perkins K.A., Coddington S.B., Karelitz J.L., Jetton C., Scott J.A., Wilson A.S., et al. Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking. Drug and Alcohol Dependence 99 (2009) 47-57
36. Perkins K.A., D'Amico D., Sanders M., Grobe J.E., Wilson A., and Stiller R.L. Influence of training dose on nicotine discrimination in humans. Psychopharmacology (Berlin) 126 (1996) 132-139
37. Perkins K.A., Grobe J.E., Weiss D., Fonte C., and Caggiula A. Nicotine preference in smokers as a function of smoking abstinence. Pharmacology, Biochemistry and Behavior 55 (1996) 257-263
38. Perkins K.A., Jacobs L., Sanders M., and Caggiula A.R. Sex differences in the subjective and reinforcing effects of cigarette nicotine dose. Psychopharmacology (Berlin) 163 (2002) 194-201
39. Scharf D., and Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of bupropion SR. Addiction 99 (2004) 1462-1469
40. Schneider N.G., Terrace S., Koury M.A., Patel S., Vaghaiwalla B., Pendergrass R., et al. Comparison of three nicotine treatments: Initial reactions and preferences with guided use. Psychopharmacology (Berlin) 182 (2005) 545-550
41. Schuh K.J., Schuh L.M., Henningfield J.E., and Stitzer M.L. Nicotine nasal spray and vapor inhaler: Abuse liability assessment. Psychopharmacology 130 (1997) 352-361
42. Siu E.C., Wildenauer D.B., and Tyndale R.F. Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5. Psychopharmacology (Berlin) 184 (2006) 401-408
43. Sofuoglu M., Babb D., and Hatsukami D.K. Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokers. Nicotine & Tobacco Research 5 (2003) 947-953
44. Sofuoglu M., Mooney M., and Waters A.J. Effects of minocycline on intravenous nicotine responses and smoking behavior in overnight abstinent smokers. Pharmacology Biochemistry and Behavior 92 (2008) 135-140
45. Sofuoglu M., Mouratidis M., Yoo S., Culligan K., and Kosten T. Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers. Psychopharmacology (Berlin) 181 (2005) 504-510
46. Sofuoglu M., Poling J., Mouratidis M., and Kosten T. Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers. Psychopharmacology (Berlin) 184 (2006) 645-651
47. Sofuoglu M., Yoo S., Hill K.P., and Mooney M. Self-administration of intravenous nicotine in male and female cigarette smokers. Neuropsychopharmacology 33 (2008) 715-720
48. Soria R., Stapleton J.M., Gilson S.F., Sampson-Cone A., Henningfield J.E., and London E.D. Subjective and cardiovascular effects of intravenous nicotine in smokers and non-smokers. Psychopharmacology 128 (1996) 221-226
49. Stabile L.P., and Siegfried J.M. Sex and gender differences in lung cancer. Journal of Gender-Specific Medicine 6 (2003) 37-48
50. Tiffany S.T., and Drobes D.J. The development and initial validation of a questionnaire on smoking urges. Addiction 86 (1991) 1467-1476
51. Walsh S.L., Preston K.L., Sullivan J.T., Fromme R., and Bigelow G.E. Fluoxetine alters the effects of intravenous cocaine in humans. Journal of Clinical Psychopharmacology 14 (1994) 396-407
52. Walsh S.L., Sullivan J.T., Preston K.L., Garner J.E., and Bigelow G.E. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. Journal of Pharmacology and Experimental Therapeutics 279 (1996) 524-538
53. Watson D., Clark L.A., and Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology 54 (1988) 1063-1070
54. Wetter D.W., Fiore M.C., Young T.B., McClure J.B., de Moor C.A., and Baker T.B. Gender differences in response to nicotine replacement therapy: Objective and subjective indexes of tobacco withdrawal. Experimental and Clinical Psychopharmacology 7 (1999) 135-144
55. Yilmaz O., Kanit L., Okur B.E., and Pogun S. Effects of nicotine on active avoidance learning in rats: Sex differences. Behavioural Pharmacology 8 (1997) 253-260
56. Zeman M.V., Hiraki L., and Sellers E.M. Gender differences in tobacco smoking: Higher relative exposure to smoke than nicotine in women. Journal of Women's Health and Gender-Based Medicine 11 (2002) 147-153